PRMT4 inhibitor TP-064 impacts both inflammatory and metabolic processes without changing the susceptibility for early atherosclerotic lesions in male apolipoprotein E knockout mice
2007 ◽
Vol 8
(1)
◽
pp. 13-14
◽
2011 ◽
Vol 78
(3)
◽
pp. 136-137
◽
Keyword(s):
2009 ◽
Vol 205
(1)
◽
pp. 63-73
◽
2015 ◽
Vol 18
(12)
◽
pp. 1299-1306
◽
2009 ◽
Vol 29
(2)
◽
pp. 173-179
◽
2014 ◽
Vol 23
(4)
◽
pp. 1267-1272
◽